Basis: Trailing twelve months (TTM), to the latest fiscal quarter end. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the return on invested capital (ROIC) high or low?
The return on invested capital (ROIC) of 4.59% is 129% above its 5-year average of -15.64%, near the high end of its 5-year range (-84.10%–37.60%).
As of the fiscal period ended Tuesday, June 30, 2026. 78.48% below its 12-month average of 21.31%.
Trailing-twelve-month return on invested capital at each fiscal quarter end; no daily interpolation. Q2 FY2026 (2026-06-30): 4.59%.
RETURN ON INVESTED CAPITAL (ROIC)
4.59%
RETURN ON INVESTED CAPITAL (ROIC) AVG TTM
21.31%
RETURN ON INVESTED CAPITAL (ROIC) AVG 3Y
-9.56%
RETURN ON INVESTED CAPITAL (ROIC) AVG 5Y
-15.64%
RETURN ON INVESTED CAPITAL (ROIC) AVG 10Y
-20.65%
RETURN ON INVESTED CAPITAL (ROIC) AVG 15Y
N/A
RETURN ON INVESTED CAPITAL (ROIC) AVG 20Y
N/A
CURRENT VS TTM AVG
-78.48%
CURRENT VS 3Y AVG
+147.98%
CURRENT VS 5Y AVG
+129.33%
CURRENT VS 10Y AVG
+122.21%
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
-34.77%
median of 763 covered companies
CURRENT VS SECTOR MEDIAN
+113.19%
vs the sector median at left
PTC Therapeutics, Inc.
Market Cap
$5.31B
Return on Invested Capital (ROIC)
4.59%
TTM Avg
21.31%
3Y Avg
-9.56%
5Y Avg
-15.64%
Market Cap
$5.32B
Return on Invested Capital (ROIC)
15.35%
TTM Avg
17.38%
3Y Avg
14.85%
5Y Avg
17.21%
Market Cap
$5.26B
Return on Invested Capital (ROIC)
8.80%
TTM Avg
6.38%
3Y Avg
6.96%
5Y Avg
7.04%
Market Cap
$5.19B
Return on Invested Capital (ROIC)
-21.12%
TTM Avg
-24.05%
3Y Avg
-22.50%
5Y Avg
-16.04%
Market Cap
$5.18B
Return on Invested Capital (ROIC)
-50.09%
TTM Avg
-69.73%
3Y Avg
-67.26%
5Y Avg
-56.46%
Market Cap
$5.52B
Return on Invested Capital (ROIC)
0.43%
TTM Avg
-2.29%
3Y Avg
-2.17%
5Y Avg
-2.17%
Market Cap
$5.09B
Return on Invested Capital (ROIC)
-90.04%
TTM Avg
-83.71%
3Y Avg
-67.61%
5Y Avg
-57.95%
Market Cap
$5.53B
Return on Invested Capital (ROIC)
1.41%
TTM Avg
2.38%
3Y Avg
2.50%
5Y Avg
2.69%
Market Cap
$5.07B
Return on Invested Capital (ROIC)
-38.03%
TTM Avg
-36.93%
3Y Avg
-41.32%
5Y Avg
-48.18%
| NAME | MARKET CAP | RETURN ON INVESTED CAPITAL (ROIC) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| PTC Therapeutics, Inc. (PTCT) | $5.31B | 4.59% | 21.31% | -9.56% | -15.64% |
| Doximity, Inc. (DOCS)vs › | $5.32B | 15.35% | 17.38% | 14.85% | 17.21% |
| Sotera Health Company (SHC)vs › | $5.26B | 8.80% | 6.38% | 6.96% | 7.04% |
| CRISPR Therapeutics AG (CRSP)vs › | $5.19B | -21.12% | -24.05% | -22.50% | -16.04% |
| Cogent Biosciences, Inc. (COGT)vs › | $5.18B | -50.09% | -69.73% | -67.26% | -56.46% |
| MiniMed Group, Inc. Common Stock (MMED)vs › | $5.52B | 0.43% | -2.29% | -2.17% | -2.17% |
| Scholar Rock Holding Corporation (SRRK)vs › | $5.09B | -90.04% | -83.71% | -67.61% | -57.95% |
| RadNet, Inc. (RDNT)vs › | $5.53B | 1.41% | 2.38% | 2.50% | 2.69% |
| Erasca, Inc. (ERAS)vs › | $5.07B | -38.03% | -36.93% | -41.32% | -48.18% |
| Merit Medical Systems, Inc. (MMSI)vs › | $5.07B | 5.80% | 5.65% | 5.40% | 4.23% |
ROIC
4.6%
ROE
N/A
ROIC = NOPAT / Invested Capital, where NOPAT = Operating Income × (1 − effective tax rate) and Invested Capital = Total Assets − (Current Liabilities − Short-Term Debt)
Return on invested capital measures the after-tax operating return a company earns on the capital invested in the business. TGMCharts computes it from reported statements: trailing-twelve-month operating income after tax, over invested capital at the latest balance sheet — total assets less the non-interest-bearing current liabilities (payables, accruals, deferred revenue) that fund them; short-term debt stays in the capital base. The tax rate is the period's own effective rate (income tax ÷ pretax income), capped at 45%; when pretax income is zero or negative, or the tax line is a net benefit, no tax is deducted — the operating figure is shown untaxed rather than adjusted by an assumed rate. Not shown for banks, insurers or funds.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | RETURN ON INVESTED CAPITAL (ROIC) |
|---|---|
| 2026-06-30 | 4.59% |
| 2026-03-31 | -3.03% |
| 2025-12-31 | 33.58% |
| 2025-09-30 | 37.60% |
| 2025-06-30 | 33.82% |
| 2025-03-31 | 31.61% |
| 2024-12-31 | -21.90% |
| 2024-09-30 | -11.13% |
| 2024-06-30 | -15.36% |
| 2024-03-31 | -30.45% |
| 2023-12-31 | -29.74% |
| 2023-09-30 | -84.10% |
| 2023-06-30 | -69.74% |
| 2023-03-31 | -41.45% |
| 2022-12-31 | -33.01% |
| 2022-09-30 | -29.15% |
| 2022-06-30 | -25.72% |
| 2022-03-31 | -24.64% |
| 2021-12-31 | -22.87% |
| 2021-09-30 | -22.83% |
| 2021-06-30 | -19.69% |
| 2021-03-31 | -23.48% |
| 2020-12-31 | -22.36% |
| 2020-09-30 | -21.18% |
| 2020-06-30 | -31.98% |
| 2020-03-31 | -19.66% |
| 2019-12-31 | -17.13% |
| 2019-09-30 | -14.45% |
| 2019-06-30 | -17.69% |
| 2019-03-31 | -14.52% |
| 2018-12-31 | -12.00% |
| 2018-09-30 | -7.07% |
| 2018-06-30 | -11.19% |
| 2018-03-31 | -17.83% |
| 2017-12-31 | -20.77% |
| 2017-09-30 | -32.02% |
| 2017-06-30 | -30.44% |
| 2017-03-31 | -59.03% |
| 2016-12-31 | -60.10% |
| 2016-09-30 | -64.90% |
| 2016-06-30 | -62.99% |
| 2016-03-31 | -57.49% |
| 2015-12-31 | -51.80% |
| 2015-09-30 | -41.48% |
| 2015-06-30 | -54.45% |
| 2015-03-31 | -44.73% |
| 2014-12-31 | -33.06% |
| 2014-09-30 | -41.90% |
| 2014-06-30 | -27.41% |
| 2014-03-31 | -20.69% |
| 2013-12-31 | -32.70% |
| 2013-09-30 | -21.73% |
| 2013-06-30 | -22.80% |
| 2013-03-31 | -71.30% |
